Check Cap Stock Price, News & Analysis (NASDAQ:CHEK)

$0.76 +0.01 (+1.33 %)
(As of 02/18/2018 03:47 AM ET)
Previous Close$0.76
Today's Range$0.72 - $0.78
52-Week Range$0.60 - $2.38
Volume23,223 shs
Average Volume393,611 shs
Market Capitalization$14.64 million
P/E Ratio-1.25
Dividend YieldN/A
BetaN/A

About Check Cap (NASDAQ:CHEK)

Check Cap logoCheck-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company's system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient's back, and a personal computer (PC)-based work station for data reconstruction and image processing. The Company's scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Its scanning capsule employs low-dose X-rays, which allow the system to image the interior lining of the colon even when surrounded by intestinal content. Its capsule transmits information to a receiving device worn on the patient's body that stores the information for off-line analysis.

Receive CHEK News and Ratings via Email

Sign-up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Specialty & Advanced Pharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:CHEK
CUSIPN/A
Phone+972-4-8303401

Debt

Debt-to-Equity RatioN/A
Current Ratio4.48%
Quick Ratio4.48%

Price-To-Earnings

Trailing P/E Ratio-1.24590163934426
Forward P/E Ratio-1.25
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.72 per share
Price / Book1.06

Profitability

Trailing EPS($0.61)
Net Income$-8,820,000.00
Net MarginsN/A
Return on Equity-129.20%
Return on Assets-100.81%

Miscellaneous

Employees55
Outstanding Shares19,260,000

Check Cap (NASDAQ:CHEK) Frequently Asked Questions

What is Check Cap's stock symbol?

Check Cap trades on the NASDAQ under the ticker symbol "CHEK."

How were Check Cap's earnings last quarter?

Check Cap Ltd (NASDAQ:CHEK) announced its quarterly earnings data on Thursday, August, 10th. The medical research company reported ($0.17) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.16) by $0.01. View Check Cap's Earnings History.

When will Check Cap make its next earnings announcement?

Check Cap is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for Check Cap.

Where is Check Cap's stock going? Where will Check Cap's stock price be in 2018?

2 brokers have issued 1 year target prices for Check Cap's shares. Their predictions range from $5.00 to $6.00. On average, they expect Check Cap's share price to reach $5.50 in the next twelve months. View Analyst Ratings for Check Cap.

What are Wall Street analysts saying about Check Cap stock?

Here are some recent quotes from research analysts about Check Cap stock:

  • 1. According to Zacks Investment Research, "Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. " (1/31/2018)
  • 2. Maxim Group analysts commented, "Summary Check-Cap announced that the company has filed for the CE Mark registration of C-Scan. Sure, that is positive news. We worry that the reported 44% sensitivity" in N=45 subjects is low but we see room for that number to rise with improved software. The press release goes on to state that in the analysis for polyps, specificity was 89%". Sensitivity strongly correlated (R-squared = 0.98) to the percentage of the colon scanned. Sensitivity was 78% (p<0.05) and 100% (p<0.05) for subjects where greater than 50% and 70% of the colon was scanned, respectively. Specificity was consistent for all subjects. We conclude that for CE Mark and in Europe where the standard of care is comparable (stool test) that the data should support an approval. We also recognize however that the US standard will be much higher as the US comparison must be colonoscopy (85-90%) sensitive."" (9/27/2017)
  • 3. HC Wainwright analysts commented, "We note that this trial is designed to evaluate C-Scan’s ability to detect polyps as compared to colonoscopy. We expect a total data package of around 150 subjects to be submitted for CE Mark approval, which may potentially lead to European market entry in 2018. In the wake of this update, we reiterate our Buy rating and $6 price target. GE Healthcare collaboration awarded $1M grant. Check-Cap and GE Healthcare (GE; not rated) received approval of a $1M conditional grant from the Israel-U.S. Binational Industrial Research and Development Foundation (BIRD). The grant is to support development of a high- volume manufacturing process for the C-Scan system’s X-ray source and capsule assembly, and establish a unique product distribution process for a pilot clinical trial in the U.S." (8/11/2017)

Who are some of Check Cap's key competitors?

Who are Check Cap's key executives?

Check Cap's management team includes the folowing people:

  • Tomer Kariv, Chairman of the Board (Age 56)
  • William Densel, Chief Executive Officer, Director (Age 48)
  • Lior Torem CPA, Chief Financial Officer (Age 46)
  • Yoav Kimchy Ph.D., Chief Technology Officer (Age 54)
  • Alex Ovadia, Vice President - Research & Development (Age 53)
  • Mary Jo Gorman M.D., External Director (Age 56)
  • XiangQian Lin, Director (Age 32)
  • Walter L. Robb Ph.D., Director (Age 87)
  • Yuval Yanai, External Director (Age 65)
  • Steven J. Hanley, Independent Director (Age 48)

When did Check Cap IPO?

(CHEK) raised $13 million in an initial public offering on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager.

Who owns Check Cap stock?

Check Cap's stock is owned by a number of of retail and institutional investors. Top institutional investors include Sabby Management LLC (5.23%), Armistice Capital LLC (3.88%) and Anson Funds Management LP (1.73%). View Institutional Ownership Trends for Check Cap.

Who sold Check Cap stock? Who is selling Check Cap stock?

Check Cap's stock was sold by a variety of institutional investors in the last quarter, including Sabby Management LLC. View Insider Buying and Selling for Check Cap.

Who bought Check Cap stock? Who is buying Check Cap stock?

Check Cap's stock was bought by a variety of institutional investors in the last quarter, including Armistice Capital LLC and Anson Funds Management LP. View Insider Buying and Selling for Check Cap.

How do I buy Check Cap stock?

Shares of Check Cap can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Check Cap's stock price today?

One share of Check Cap stock can currently be purchased for approximately $0.76.

How big of a company is Check Cap?

Check Cap has a market capitalization of $14.64 million. The medical research company earns $-8,820,000.00 in net income (profit) each year or ($0.61) on an earnings per share basis. Check Cap employs 55 workers across the globe.

How can I contact Check Cap?

The medical research company can be reached via phone at +972-4-8303401.


MarketBeat Community Rating for Check Cap (CHEK)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  227
MarketBeat's community ratings are surveys of what our community members think about Check Cap and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Check Cap (NASDAQ:CHEK) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.50$5.67$6.00$6.00
Price Target Upside: 547.06% upside566.67% upside217.46% upside242.86% upside

Check Cap (NASDAQ:CHEK) Consensus Price Target History

Price Target History for Check Cap (NASDAQ:CHEK)

Check Cap (NASDAQ:CHEK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/11/2018HC WainwrightBoost Price TargetBuy -> Buy$5.50 -> $6.00HighView Rating Details
9/27/2017Maxim GroupReiterated RatingBuy$5.00HighView Rating Details
1/19/2017Rodman & RenshawInitiated CoverageBuy$6.00N/AView Rating Details
5/20/2016Chardan CapitalLower Price TargetBuy$6.00 -> $4.00N/AView Rating Details
(Data available from 2/18/2016 forward)

Earnings

Check Cap (NASDAQ:CHEK) Earnings History and Estimates Chart

Earnings by Quarter for Check Cap (NASDAQ:CHEK)

Check Cap (NASDAQ CHEK) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018($0.15)N/AView Earnings Details
11/6/2017Q3 2017($0.18)($0.13)ViewN/AView Earnings Details
8/10/20176/30/2017($0.16)($0.17)ViewN/AView Earnings Details
5/9/2017Q1 2017($0.16)($0.16)ViewN/AView Earnings Details
3/9/201712/31/2016($0.14)($0.15)ViewN/AView Earnings Details
11/16/2016Q316($0.14)($0.11)ViewN/AView Earnings Details
8/15/2016Q2 2016($0.15)ViewN/AView Earnings Details
5/19/2016Q1 2016($0.21)ViewN/AView Earnings Details
3/15/2016Q4 2015($0.22)ViewN/AView Earnings Details
10/22/2015Q3 2015($0.01)ViewN/AView Earnings Details
7/21/2015Q2 2015($0.30)ViewN/AView Earnings Details
6/4/2015Q1 2015($0.53)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Check Cap (NASDAQ:CHEK) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.61 EPS
Next Year EPS Consensus Estimate: $-0.54 EPS

Dividends

Dividend History for Check Cap (NASDAQ:CHEK)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Check Cap (NASDAQ CHEK)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Check Cap (NASDAQ CHEK) News Headlines

Source:
DateHeadline
Zacks: Analysts Expect Check Cap Ltd (CHEK) to Post -$0.14 Earnings Per ShareZacks: Analysts Expect Check Cap Ltd (CHEK) to Post -$0.14 Earnings Per Share
www.americanbankingnews.com - February 1 at 7:22 PM
Check Cap (CHEK) Lowered to "Hold" at Zacks Investment ResearchCheck Cap (CHEK) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - January 31 at 9:18 PM
Check-Cap Announces Receipt of Nasdaq Minimum Bid Price NotificationCheck-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification
finance.yahoo.com - January 27 at 7:12 AM
Check Cap (CHEK) Rating Increased to Buy at Zacks Investment ResearchCheck Cap (CHEK) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - January 15 at 10:28 PM
 Brokerages Expect Check Cap Ltd (CHEK) to Post -$0.14 Earnings Per Share Brokerages Expect Check Cap Ltd (CHEK) to Post -$0.14 Earnings Per Share
www.americanbankingnews.com - January 15 at 9:14 PM
Check Cap (CHEK) Given New $6.00 Price Target at HC WainwrightCheck Cap (CHEK) Given New $6.00 Price Target at HC Wainwright
www.americanbankingnews.com - January 11 at 8:16 AM
Check-Cap (CHEK) Receives CE Mark Approval for C-ScanCheck-Cap (CHEK) Receives CE Mark Approval for C-Scan
www.streetinsider.com - January 10 at 5:26 PM
 Analysts Set $4.42 Target Price for Check Cap Ltd (CHEK) Analysts Set $4.42 Target Price for Check Cap Ltd (CHEK)
www.americanbankingnews.com - January 10 at 4:06 AM
 Brokerages Anticipate Check Cap Ltd (CHEK) to Post -$0.14 Earnings Per Share Brokerages Anticipate Check Cap Ltd (CHEK) to Post -$0.14 Earnings Per Share
www.americanbankingnews.com - December 30 at 1:24 AM
Zacks: Analysts Set $4.42 Price Target for Check Cap Ltd (CHEK)Zacks: Analysts Set $4.42 Price Target for Check Cap Ltd (CHEK)
www.americanbankingnews.com - December 26 at 1:10 AM
Critical Review: Check Cap (CHEK) & DARA Biosciences (DARA)Critical Review: Check Cap (CHEK) & DARA Biosciences (DARA)
www.americanbankingnews.com - December 22 at 7:16 AM
Check Cap Ltd (CHEK) Expected to Announce Earnings of -$0.14 Per ShareCheck Cap Ltd (CHEK) Expected to Announce Earnings of -$0.14 Per Share
www.americanbankingnews.com - December 12 at 9:30 PM
Zacks: Check Cap Ltd (CHEK) Given $4.42 Consensus Price Target by BrokeragesZacks: Check Cap Ltd (CHEK) Given $4.42 Consensus Price Target by Brokerages
www.americanbankingnews.com - December 9 at 1:22 AM
Check-Cap Ltd (CHEK): The Yield That Matters The MostCheck-Cap Ltd (CHEK): The Yield That Matters The Most
finance.yahoo.com - December 6 at 9:31 AM
Check-Cap Announces Advancement in GE Healthcare Manufacturing CollaborationCheck-Cap Announces Advancement in GE Healthcare Manufacturing Collaboration
finance.yahoo.com - December 5 at 10:02 AM
Check-Cap (CHEK) Downgraded by Zacks Investment ResearchCheck-Cap (CHEK) Downgraded by Zacks Investment Research
www.americanbankingnews.com - December 1 at 6:58 PM
HC Wainwright Lowers Check-Cap (CHEK) Price Target to $5.50HC Wainwright Lowers Check-Cap (CHEK) Price Target to $5.50
www.americanbankingnews.com - November 28 at 7:50 PM
Zacks: Check-Cap Ltd. (CHEK) Receives Consensus Rating of "Strong Buy" from BrokeragesZacks: Check-Cap Ltd. (CHEK) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - November 26 at 3:16 PM
Reviewing Mallinckrodt PLC (MNK) and Check-Cap (CHEK)Reviewing Mallinckrodt PLC (MNK) and Check-Cap (CHEK)
www.americanbankingnews.com - November 24 at 3:28 AM
Check-Cap Ltd. Announces Closing of $2.5 Million Registered Direct OfferingCheck-Cap Ltd. Announces Closing of $2.5 Million Registered Direct Offering
finance.yahoo.com - November 22 at 5:54 PM
Reviewing Mallinckrodt PLC (MNK) & Check-Cap (CHEK)Reviewing Mallinckrodt PLC (MNK) & Check-Cap (CHEK)
www.americanbankingnews.com - November 21 at 5:12 AM
Check-Cap (CHEK) Announces $2.5M Registered Direct Offering of Ordinary Shares and Warrants - StreetInsider.comCheck-Cap (CHEK) Announces $2.5M Registered Direct Offering of Ordinary Shares and Warrants - StreetInsider.com
www.streetinsider.com - November 21 at 4:17 AM
Is Check-Cap Ltd (CHEK) Thriving Or Barely Surviving In The Healthcare Sector?Is Check-Cap Ltd (CHEK) Thriving Or Barely Surviving In The Healthcare Sector?
finance.yahoo.com - November 20 at 11:17 PM
Check-Cap Ltd. Announces $2.5 Million Registered Direct OfferingCheck-Cap Ltd. Announces $2.5 Million Registered Direct Offering
finance.yahoo.com - November 20 at 6:15 PM
Check-Cap (CHEK) & Assembly Biosciences (ASMB) Head to Head SurveyCheck-Cap (CHEK) & Assembly Biosciences (ASMB) Head to Head Survey
www.americanbankingnews.com - November 7 at 5:34 AM
Check-Cap Ltd. (CHEK) Set to Announce Earnings on TuesdayCheck-Cap Ltd. (CHEK) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - November 7 at 3:02 AM
Check-Cap Reports Third Quarter 2017 Financial ResultsCheck-Cap Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 6 at 6:20 PM
Check-Cap Ltd. (CHEK) Expected to Announce Earnings of -$0.16 Per ShareCheck-Cap Ltd. (CHEK) Expected to Announce Earnings of -$0.16 Per Share
www.americanbankingnews.com - November 6 at 3:24 AM
Head to Head Review: Mallinckrodt PLC (MNK) vs. Check-Cap (CHEK)Head to Head Review: Mallinckrodt PLC (MNK) vs. Check-Cap (CHEK)
www.americanbankingnews.com - October 30 at 11:24 PM
Health Care Sector Update for 10/24/2017: CHEK,PTIE,IMDZ - NasdaqHealth Care Sector Update for 10/24/2017: CHEK,PTIE,IMDZ - Nasdaq
www.nasdaq.com - October 25 at 12:32 AM
Check-Cap (CHEK) Reports Acceptance of Late Breaking Abstract at UEG - StreetInsider.comCheck-Cap (CHEK) Reports Acceptance of Late Breaking Abstract at UEG - StreetInsider.com
www.streetinsider.com - October 25 at 12:32 AM
Check-Cap Announces Acceptance of Late Breaking Clinical Performance Abstract at United European Gastroenterology Week 2017Check-Cap Announces Acceptance of Late Breaking Clinical Performance Abstract at United European Gastroenterology Week 2017
finance.yahoo.com - October 24 at 7:29 PM
Financial Survey: Check-Cap (CHEK) versus The CompetitionFinancial Survey: Check-Cap (CHEK) versus The Competition
www.americanbankingnews.com - October 4 at 10:24 PM
Reviewing Check-Cap (CHEK) & Its RivalsReviewing Check-Cap (CHEK) & Its Rivals
www.americanbankingnews.com - October 3 at 4:22 PM
Financial Comparison: Check-Cap (CHEK) versus Its CompetitorsFinancial Comparison: Check-Cap (CHEK) versus Its Competitors
www.americanbankingnews.com - September 30 at 6:14 PM
Comparing Check-Cap (CHEK) and Its CompetitorsComparing Check-Cap (CHEK) and Its Competitors
www.americanbankingnews.com - September 28 at 8:30 PM
HC Wainwright Reaffirms "Buy" Rating for Check-Cap Ltd. (CHEK)HC Wainwright Reaffirms "Buy" Rating for Check-Cap Ltd. (CHEK)
www.americanbankingnews.com - September 28 at 8:20 PM
 Analysts Anticipate Check-Cap Ltd. (CHEK) to Announce -$0.16 EPS Analysts Anticipate Check-Cap Ltd. (CHEK) to Announce -$0.16 EPS
www.americanbankingnews.com - September 28 at 6:14 PM
Check-Cap (CHEK) Files CE Mark Registration for C-Scan - SlideshowCheck-Cap (CHEK) Files CE Mark Registration for C-Scan - Slideshow
seekingalpha.com - September 28 at 5:09 PM
Reviewing Check-Cap (CHEK) & Its PeersReviewing Check-Cap (CHEK) & Its Peers
www.americanbankingnews.com - September 28 at 6:22 AM
Check-Cap Ltd. (CHEK) Earns Buy Rating from Maxim GroupCheck-Cap Ltd. (CHEK) Earns Buy Rating from Maxim Group
www.americanbankingnews.com - September 27 at 8:44 PM
Check-Cap Announces Filing of CE Mark Registration for C-Scan®Check-Cap Announces Filing of CE Mark Registration for C-Scan®
www.prnewswire.com - September 27 at 5:32 PM
Head to Head Review: Check-Cap (CHEK) versus NOVAN INC (NOVN)Head to Head Review: Check-Cap (CHEK) versus NOVAN INC (NOVN)
www.americanbankingnews.com - September 19 at 4:36 AM
Critical Survey: Check-Cap (CHEK) vs. its RivalsCritical Survey: Check-Cap (CHEK) vs. its Rivals
www.americanbankingnews.com - September 9 at 6:22 PM
Reviewing AbbVie (ABBV) & Check-Cap (CHEK)Reviewing AbbVie (ABBV) & Check-Cap (CHEK)
www.americanbankingnews.com - September 9 at 11:04 AM
Head to Head Review: Check-Cap (CHEK) and Eagle Pharmaceuticals (EGRX)Head to Head Review: Check-Cap (CHEK) and Eagle Pharmaceuticals (EGRX)
www.americanbankingnews.com - August 29 at 4:22 PM
Critical Analysis: Check-Cap (CHEK) and Rockwell Medical (RMTI)Critical Analysis: Check-Cap (CHEK) and Rockwell Medical (RMTI)
www.americanbankingnews.com - August 24 at 4:08 AM
Head to Head Analysis: Check-Cap (CHEK) and Aimmune Therapeutics (AIMT)Head to Head Analysis: Check-Cap (CHEK) and Aimmune Therapeutics (AIMT)
www.americanbankingnews.com - August 23 at 6:28 AM
Reviewing Check-Cap (CHEK) and Supernus Pharmaceuticals (SUPN)Reviewing Check-Cap (CHEK) and Supernus Pharmaceuticals (SUPN)
www.americanbankingnews.com - August 17 at 8:26 PM
Check-Cap Ltd. (CHEK) Given a $6.00 Price Target by HC Wainwright AnalystsCheck-Cap Ltd. (CHEK) Given a $6.00 Price Target by HC Wainwright Analysts
www.americanbankingnews.com - August 13 at 4:38 PM

SEC Filings

Check Cap (NASDAQ:CHEK) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Check Cap (NASDAQ:CHEK) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Check Cap (NASDAQ CHEK) Stock Chart for Sunday, February, 18, 2018

Loading chart…

This page was last updated on 2/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.